GhanaReview International - The Leading Ghanaian News Agency
London New York Accra
International
Thursday 21 November 2024

2021-03-19

[I] Goldman Sachs staff revolt at ‘98-hour week’
[I] Over half of staff go back to workplace
[I] Health chiefs confirm Oxford-AstraZeneca Covid jab safe to use

2021-03-17

[I] Half of UK managers back mandatory Covid vaccines for office work
[I] Brussels to propose Covid certificate to allow EU-wide travel

2021-03-16

[I] Nick Candy leads £1m drive to oust London mayor Sadiq Khan
[I] UK defends Oxford Covid vaccine over fears of blood clots

2021-03-14

[I] Emirates will now let you pay to not sit next to a stranger

2021-03-12

[I] Biden eyes 4 July as ‘Independence Day’ from virus
[I] Royal family ‘very much not racist’, insists duke

2021-03-10

[I] England’s £23bn test and trace programme condemned by MPs
[I] FUFA rewards Hippos Team with $ 160,000

2021-03-09

[I] The advice on drinking alcohol and taking ibuprofen after having a Covid vaccine
[I] Royal family in turmoil over Meghan’s racism claims in Oprah interview

2021-03-03

[I] Huawei to more than halve smartphone output in 2021
[I] Covid vaccines show few serious side-effects after millions of jabs

2021-03-01

[I] Employers aim for hybrid working after Covid-19 pandemic
[I] Hunt for mystery person who tested positive for Brazilian Covid-19 variant
[I] Trump teases supporters with hint of new presidential run

2021-02-28

[I] 32m Covid tests by post to reopen schools

2021-02-25

[I] Watchdog strengthens audit rules for KPMG, EY, Deloitte and PWC
[I] US set to approve Johnson & Johnson’s single dose Covid vaccine

2021-02-22

[I] Vaccines cut Covid hospital admissions by up to 94%
[I] Bond trading finally dragged into the digital age

2021-02-19

[I] US will not send vaccines to developing countries until supply improves
[I] Macron urges Europe to send vaccines to Africa now

2021-02-18

[I] Covid infections dropping fast across England, study shows

2021-02-17

[I] KPMG appoints first female leaders
[I] No jabs, no jobs

2021-02-16

[I] Covid vaccines are reducing UK admissions and deaths
[I] Are planes as Covid-safe as the airlines say?

2021-02-15

[I] Heathrow arrivals escorted to £1,750 hotel isolation

2021-02-14

[I] Auditor Grant Thornton ‘failed to check Patisserie Valerie cash levels’
[I] UK returns to school in three weeks
[I] Harry and Meghan expecting second child
[I] UK Premier hails ‘extraordinary feat’ of 15m jabs

2021-02-11

[I] AstraZeneca on course to roll out vaccine for new Covid variants by autumn

2021-02-10

[I] UK - Covid-19: 10-year jail term for travel lies defended
[I] Ghanaian-born surgeon 'to help Gorilla Glue woman'

2021-02-09

[I] UK weather: Snow disruption continues as temperatures plummet
... go Back
 
International

[ 2021-03-16 ]

UK defends Oxford Covid vaccine over fears of blood clots
British and European regulators rushed to the
defence of the Oxford-AstraZeneca Covid-19 vaccine
last night as six more countries stopped using it
over unconfirmed links to blood clots.

Germany, France, Spain, Italy, the Netherlands and
Portugal announced temporary pauses pending an
investigation by the European Medicines Agency
(EMA), which is due to report by Thursday.

However, the European regulator said blood clots
seemed to be no more common among people who had
received the Oxford-AstraZeneca jab and insisted
that the benefits of it “outweigh the risks of
side-effects”.

Boris Johnson reiterated his support for the
Oxford-AstraZeneca vaccine on a visit to Coventry,
where he toured the National Express depot
Boris Johnson reiterated his support for the
Oxford-AstraZeneca vaccine on a visit to Coventry,
where he toured the National Express depot


The UK Medicines and Healthcare Products
Regulatory Agency (MHRA) said it did not think the
jab caused blood clots after studying data on 11
million people given it in Britain, and Boris
Johnson also supported the vaccine.

A spokesman for the World Health Organisation
(WHO) said there was no evidence the vaccine
caused blood clots and urged countries to keep
using it.

It means Britain and large European countries are
again divided over the Oxford-AstraZeneca vaccine,
which is widely mistrusted on the Continent after
rows about efficacy in older people. Ireland,
Denmark, Norway, Bulgaria and Iceland have also
temporarily stopped using it, delaying vaccination
programmes that are already far behind
Britain’s.

In other developments:

• Britain recorded 64 deaths yesterday, with the
seven-day total down by 29.6 per cent. There were
5,089 new cases, with the seven-day total 2.3 per
cent lower than the previous week.

• The Office for National Statistics said more
deaths were caused by Covid-19 in 2020 than have
been attributed to an infectious disease in any
year for more than a century.

• The governor of the Bank of England said the
economy would return to its pre-Covid size by the
end of the year.

• Experts said urgent action was needed to stop
cancer deaths rising for the first time in
decades.

• Ministers announced that Portugal would be
removed from a “red list” of banned
destinations, signalling the go-ahead for holidays
this summer.

All people over 56 have been invited to have the
jab, at sites such as the community vaccination
centre at Kingston University’s Penrhyn Road
campus
All people over 56 have been invited to have the
jab, at sites such as the community vaccination
centre at Kingston University’s Penrhyn Road
campus

The EMA said last week that it had been alerted to
30 cases of blood clots, including one death,
among five million people who had been given the
Oxford-AstraZeneca vaccine. Last night it stressed
that “many thousands of people develop blood
clots annually in the EU for different reasons”
and the number among vaccinated people “seems
not to be higher than that in the general
population”.

SPONSORED


Jens Spahn, Germany’s health minister, said the
suspension had been imposed as a “purely
precautionary measure”, after the country’s
vaccines agency said further cases had come to
light.

President Macron of France said the suspension had
been imposed “as a precaution, hoping that we
can resume its use quickly if the EMA allows”.

Source - The Times, UK



... go Back

 
Add YOUR View here

Ghana Review International (GRi) is published by Micromedia Consultants Ltd. T/A MCL - a wholly Ghanaian owned news agency. GRi is an independent publication and is non-aligned to any political party or interest group, within or outside of Ghana. It is a reliable source of information for Ghanaians and non-Ghanaians alike. This magazine will be of interest to any person with an interest in Ghana, Ghanaians and Africans, wherever in the world they live. This website is the on-line arm of the publication. It contains news and reviews on Ghana and the international communities.

All pages are © Copyright Ghana Review International (GRi) 1994 - 2021